Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 2, 2026

Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

[Evolving intravitreous injection technique].

M Weber1, S Y Cohen, R Tadayoni

  • 1Service d'ophtalmologie, CHU Hôtel-Dieu, Nantes, France. michel.weber@chu-nantes.fr

Journal Francais D'Ophtalmologie
|September 6, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A hidden stone in the eye: Mysteries of the choroidal osteoma].

Journal francais d'ophtalmologie·2026
Same author

PICCTURE: Survey of French ophthalmologists' practices for the treatment of neovascular age-related macular degeneration patients currently treated with anti-VEGF.

Journal francais d'ophtalmologie·2026
Same author

[Mirvetuximab soravtansine-associated microcystic keratopathy].

Journal francais d'ophtalmologie·2026
Same author

Functional and anatomic outcomes of brolucizumab in adults with neovascular age-related macular degeneration - The OCTOPUS cohort study.

Journal francais d'ophtalmologie·2025
Same author

Disease control, visual and anatomic outcomes at week 48 of brolucizumab treatment in patients with previously suboptimal anatomically controlled neovascular age-related macular degeneration - The SWIFT study.

Journal francais d'ophtalmologie·2025
Same author

[Recommendations for rational use of new anti-VEGF biologicals].

Journal francais d'ophtalmologie·2025
Same journal

Silent threat to sight after bariatric surgery: Vision loss from vitamin A deficiency.

Journal francais d'ophtalmologie·2026
Same journal

Persistent subretinal fluid and subretinal precipitates following pneumatic retinopexy.

Journal francais d'ophtalmologie·2026
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
See all related articles

Intravitreous injections are increasingly common, especially with anti-VEGF drugs. This paper refines intravitreous injection techniques, simplifying procedures and tailoring patient monitoring for better comprehension and practice.

Area of Science:

  • Ophthalmology
  • Surgical Procedures

Background:

  • Intravitreous injections are a well-established ophthalmic procedure.
  • Recent availability of anti-VEGF drugs has led to a significant increase in intravitreous injections.
  • Previous recommendations and descriptive articles exist, including those from AFSSAPS.

Purpose of the Study:

  • To describe current practices for intravitreous injections.
  • To propose modifications to existing recommendations based on expert experience.
  • To simplify and standardize aspects of the intravitreous injection procedure.

Main Methods:

  • A synthesis of experiences from multiple specialists.
  • Review and modification of existing intravitreous injection protocols.
  • Focus on practical changes to enhance procedure and follow-up.

More Related Videos

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jul 2, 2026

Intravitreous Injection for Establishing Ocular Diseases Model
05:37

Intravitreous Injection for Establishing Ocular Diseases Model

Published on: October 1, 2007

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Main Results:

  • Suggested modifications include abandoning preoperative pupil dilation and easing post-surgical monitoring.
  • Follow-up examinations should be individualized rather than systematic.
  • The core intravitreous injection technique remains substantially unchanged but simplified.

Conclusions:

  • The proposed modifications simplify intravitreous injection procedures.
  • Individualized patient follow-up is recommended.
  • These refinements aim to improve the comprehension and execution of intravitreous injections.